Individual variation is substantialsome people lose weight rapidly while others experience steady, gradual progress
Furthermore, a social media study analyzing anonymous online reports demonstrated that individuals, without reported weight, on GLP-1R agonist treatment self-report a lower incidence of desire to consume alcohol, interest in alcohol, and alcohol consumption (38)
These include the severity of deficiency, patient age, and malabsorption issues
Another method to interpret the data is to elucidate the dose-response and metabolic-context dependence in animal and in vitro research
Corrado, Revolution Medicines medical director in Washington, DC, speaks with the American Heart Association about how to navigate conversations with patients in weight management